Kitakaze M - Search Results

1

Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study).

Asakura M, Kim J, Asanuma H, Nakama Y, Tsukahara K, Higashino Y, Ishikawa T, Koba S, Tsujimoto M, Himeno H, Maruyama Y, Ookusa T, Yoda S, Suzuki H, Okubo S, Shimizu M, Hashimoto Y, Satake K, Fujino S, Uzui H, Nagai Y, Kohno T, Mizuno S, Nakahama M, Kanaya H, Murohara T, Fukui K, Takase H, Ohte N, Shiono T, Fukunami M, Endo T, Sawada R, Fujii K, Takeuchi M, Ikeda S, Mizuno K, Uematsu M, Matsubara T, Yano S, Takahashi J, Ueda K, Kinoshita Y, Tamita K, Hayashi H, Hamasaki T, Kitakaze M; PPAR investigators. Asakura M, et al. Among authors: kitakaze m. EClinicalMedicine. 2018 Oct 22;4-5:10-24. doi: 10.1016/j.eclinm.2018.09.006. eCollection 2018 Oct-Nov. EClinicalMedicine. 2018. PMID: 31193597 Free PMC article.

2

Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of "preconditioning".

Nakagawa Y, Ito H, Kitakaze M, Kusuoka H, Hori M, Kuzuya T, Higashino Y, Fujii K, Minamino T. Nakagawa Y, et al. Among authors: kitakaze m. J Am Coll Cardiol. 1995 Apr;25(5):1076-83. doi: 10.1016/0735-1097(94)00542-x. J Am Coll Cardiol. 1995. PMID: 7897119 Free article.

3

Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.

Minamino T, Kitakaze M, Sato H, Asanuma H, Funaya H, Koretsune Y, Hori M. Minamino T, et al. Among authors: kitakaze m. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3191-5. doi: 10.1161/01.atv.17.11.3191. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409310

4

Antecedent angina pectoris as a predictor of better functional and clinical outcomes in patients with an inferior wall acute myocardial infarction.

Inoue K, Ito H, Kitakaze M, Kuzuya T, Hori M, Iwakura K, Nishikawa N, Higashino Y, Fujii K, Minamino T. Inoue K, et al. Among authors: kitakaze m. Am J Cardiol. 1999 Jan 15;83(2):159-63. doi: 10.1016/s0002-9149(98)00817-0. Am J Cardiol. 1999. PMID: 10073814 Clinical Trial.

5

Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs.

Kitakaze M, Asanuma H, Takashima S, Minamino T, Ueda Y, Sakata Y, Asakura M, Sanada S, Kuzuya T, Hori M. Kitakaze M, et al. Circulation. 2000 Jan 25;101(3):311-7. doi: 10.1161/01.cir.101.3.311. Circulation. 2000. PMID: 10645928

6

Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.

Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, Ikushima M, Tanaka K, Kitakaze M, Hori M, Higashino Y, Fujii K. Iwakura K, et al. Among authors: kitakaze m. J Am Coll Cardiol. 2001 Aug;38(2):472-7. doi: 10.1016/s0735-1097(01)01405-x. J Am Coll Cardiol. 2001. PMID: 11499740 Free article.

7

Nifedipine limits infarct size via NO-dependent mechanisms in dogs.

Asanuma H, Kitakaze M, Funaya H, Takashima S, Minamino T, Node K, Sakata Y, Asakura M, Sanada S, Shinozaki Y, Mori H, Kuzuya T, Tada M, Hori M. Asanuma H, et al. Among authors: kitakaze m. Basic Res Cardiol. 2001 Sep;96(5):497-505. doi: 10.1007/s003950170032. Basic Res Cardiol. 2001. PMID: 11605997

8

cDNA array hybridization reveals cardiac gene expression in acute ischemic murine hearts.

Kitakaze M, Asakura M, Sakata Y, Asanuma H, Sanada S, Kuzuya T, Miyazaki J, Takashima S, Hori M. Kitakaze M, et al. Cardiovasc Drugs Ther. 2001 Mar;15(2):125-30. doi: 10.1023/a:1011118828197. Cardiovasc Drugs Ther. 2001. PMID: 11669405

9

Benidipine, a long-acting Ca channel blocker, limits infarct size via bradykinin- and NO-dependent mechanisms in canine hearts.

Asanuma H, Kitakaze M, Node K, Takashima S, Sakata Y, Asakura M, Sanada S, Shinozaki Y, Mori H, Tada M, Kuzuya T, Hori M. Asanuma H, et al. Among authors: kitakaze m. Cardiovasc Drugs Ther. 2001;15(3):225-31. doi: 10.1023/a:1011964222712. Cardiovasc Drugs Ther. 2001. PMID: 11713890

10

[Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart].

Ogita H, Node K, Asanuma H, Sanada S, Takashima S, Asakura M, Kitakaze M, Hori M. Ogita H, et al. Among authors: kitakaze m. J Cardiol. 2002 Jan;39(1):55-6. J Cardiol. 2002. PMID: 11828800 Free article. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

604 results

Search Page